Targeting Inflammation in Atherosclerosis

Saturday, February 25, 2023

4:46 PM – 4:54 PM ET

Speaker(s)

Peter Libby, MD (he/him/his)

Cardiovascular Specialist
Brigham and Women's Hospital
Boston, Massachusetts, United States

Disclosure(s): Amgen: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); AstraZeneca: unpaid consultant to, or involved in clinical trials for (Ongoing); Baim Institute for Clinical Research: unpaid consultant to, or involved in clinical trials for (Ongoing); Beren Therapeutics: unpaid consultant to, or involved in clinical trials for (Ongoing); Caristo Diagnostics: Scientific Advisory Board (Ongoing); Cartesian Therapeutics: Scientific Advisory Board (Ongoing); CSL Behring: Scientific Advisory Board (Ongoing); DalCor Pharmaceuticals: Scientific Advisory Board (Ongoing); Dewpoint Therapeutics: Scientific Advisory Board (Ongoing); Esperion Therapeutics: unpaid consultant to, or involved in clinical trials for (Ongoing); Genentech: unpaid consultant to, or involved in clinical trials for (Ongoing); Kancera: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Kowa Pharmaceuticals: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); MedImmune: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Merck: unpaid consultant to, or involved in clinical trials for (Ongoing); Norvo Nordisk: unpaid consultant to, or involved in clinical trials for (Ongoing); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Olatec Therapeutics: Scientific Advisory Board (Ongoing); Pfizer: unpaid consultant to, or involved in clinical trials for (Ongoing); PlaqueTec Ltd: Scientific Advisory Board (Ongoing); Sanofi-Regeneron: unpaid consultant to, or involved in clinical trials for (Ongoing); Soley Thereapeutics: Scientific Advisory Board (Ongoing); TenSixteen Bio: Scientific Advisory Board (Ongoing); XBiotech, Inc.: Board Member (Ongoing)

Disclosure(s):

Peter Libby, MD: Amgen: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); AstraZeneca: unpaid consultant to, or involved in clinical trials for (Ongoing); Baim Institute for Clinical Research: unpaid consultant to, or involved in clinical trials for (Ongoing); Beren Therapeutics: unpaid consultant to, or involved in clinical trials for (Ongoing); Caristo Diagnostics: Scientific Advisory Board (Ongoing); Cartesian Therapeutics: Scientific Advisory Board (Ongoing); CSL Behring: Scientific Advisory Board (Ongoing); DalCor Pharmaceuticals: Scientific Advisory Board (Ongoing); Dewpoint Therapeutics: Scientific Advisory Board (Ongoing); Esperion Therapeutics: unpaid consultant to, or involved in clinical trials for (Ongoing); Genentech: unpaid consultant to, or involved in clinical trials for (Ongoing); Kancera: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Kowa Pharmaceuticals: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); MedImmune: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Merck: unpaid consultant to, or involved in clinical trials for (Ongoing); Norvo Nordisk: unpaid consultant to, or involved in clinical trials for (Ongoing); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Olatec Therapeutics: Scientific Advisory Board (Ongoing); Pfizer: unpaid consultant to, or involved in clinical trials for (Ongoing); PlaqueTec Ltd: Scientific Advisory Board (Ongoing); Sanofi-Regeneron: unpaid consultant to, or involved in clinical trials for (Ongoing); Soley Thereapeutics: Scientific Advisory Board (Ongoing); TenSixteen Bio: Scientific Advisory Board (Ongoing); XBiotech, Inc.: Board Member (Ongoing)